Candel Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,000 |
Gross Profit | -195 | -242 | -245 | -245 |
EBITDA | -10,913 | -4,318 | 7,930 | -13,438 |
EBIT | -11,108 | -4,560 | 7,685 | -13,683 |
Net Income | -11,269 | -4,796 | 7,379 | -14,073 |
Net Change In Cash | 0 | 0 | 0 | 1,000 |
Free Cash Flow | -10,380 | -8,922 | -8,619 | -5,817 |
Cash | 86,963 | 100,687 | 92,165 | 102,654 |
Basic Shares | 54,894 | 51,489 | 31,675 | 35,564 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $31 | $125 | $125 |
Gross Profit | -990 | -23,980 | 125 | 125 |
EBITDA | -52,097 | -37,431 | -16,308 | -35,839 |
EBIT | -53,087 | -38,391 | -17,086 | -36,071 |
Net Income | -55,177 | -37,939 | -18,794 | -36,124 |
Net Change In Cash | 0 | 31 | 125 | 125 |
Cost of Revenue | 47,747 | |||
Free Cash Flow | -27,039 | -34,701 | -32,716 | -24,053 |
Cash | 102,654 | 35,413 | 70,058 | 82,642 |
Basic Shares | 31,675 | 28,935 | 28,823 | 28,689 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.09 |
2025-03-31 | $0.13 |
